Lagisetty Pooja, Klasa Katarzyna, Bush Christopher, Heisler Michele, Chopra Vineet, Bohnert Amy
Division of General Internal Medicine, University of Michigan School of Medicine, Ann Arbor, Michigan, United States of America.
VA Center for Clinical Management Research, VA Ann Arbor Healthcare System, Ann Arbor, Michigan, United States of America.
PLoS One. 2017 Oct 17;12(10):e0186315. doi: 10.1371/journal.pone.0186315. eCollection 2017.
Primary care-based models for Medication-Assisted Treatment (MAT) have been shown to reduce mortality for Opioid Use Disorder (OUD) and have equivalent efficacy to MAT in specialty substance treatment facilities.
The objective of this study is to systematically analyze current evidence-based, primary care OUD MAT interventions and identify program structures and processes associated with improved patient outcomes in order to guide future policy and implementation in primary care settings.
PubMed, EMBASE, CINAHL, and PsychInfo.
We included randomized controlled or quasi experimental trials and observational studies evaluating OUD treatment in primary care settings treating adult patient populations and assessed structural domains using an established systems engineering framework.
We included 35 interventions (10 RCTs and 25 quasi-experimental interventions) that all tested MAT, buprenorphine or methadone, in primary care settings across 8 countries. Most included interventions used joint multi-disciplinary (specialty addiction services combined with primary care) and coordinated care by physician and non-physician provider delivery models to provide MAT. Despite large variability in reported patient outcomes, processes, and tasks/tools used, similar key design factors arose among successful programs including integrated clinical teams with support staff who were often advanced practice clinicians (nurses and pharmacists) as clinical care managers, incorporating patient "agreements," and using home inductions to make treatment more convenient for patients and providers.
The findings suggest that multidisciplinary and coordinated care delivery models are an effective strategy to implement OUD treatment and increase MAT access in primary care, but research directly comparing specific structures and processes of care models is still needed.
基于初级保健的药物辅助治疗(MAT)模式已被证明可降低阿片类物质使用障碍(OUD)的死亡率,且在专科物质使用治疗机构中与MAT具有同等疗效。
本研究的目的是系统分析当前基于证据的初级保健OUD MAT干预措施,并确定与改善患者结局相关的项目结构和流程,以指导未来初级保健环境中的政策制定和实施。
PubMed、EMBASE、CINAHL和PsychInfo。
我们纳入了评估成人患者群体初级保健环境中OUD治疗的随机对照试验或准实验研究以及观察性研究,并使用既定的系统工程框架评估结构域。
我们纳入了35项干预措施(10项随机对照试验和25项准实验干预措施),所有这些措施均在8个国家的初级保健环境中测试了MAT、丁丙诺啡或美沙酮。大多数纳入的干预措施采用联合多学科(专科成瘾服务与初级保健相结合)以及由医生和非医生提供者提供模式的协调护理来提供MAT。尽管报告的患者结局、流程以及使用的任务/工具存在很大差异,但成功项目中出现了类似的关键设计因素,包括由支持人员组成的综合临床团队,这些支持人员通常是高级实践临床医生(护士和药剂师)作为临床护理经理,纳入患者“协议”,并采用家庭诱导以使治疗对患者和提供者更方便。
研究结果表明,多学科和协调护理提供模式是在初级保健中实施OUD治疗并增加MAT可及性的有效策略,但仍需要直接比较护理模式的具体结构和流程的研究。